Friday, April 29, 2005

LONDON (Agence France-Presse) — Britain’s highest court ruled yesterday that the creation of so-called ‘designer babies’ to treat siblings with genetic disorders was lawful.

In a unanimous decision, the Law Lords upheld an Appeal Court judgment in April 2003 that overturned a ban on the use of in vitro fertilization treatment to help save the life of a terminally ill boy.

The boy’s parents, Raj and Shahana Hashmi, went ahead with the treatment to produce a sibling, hoping to have a baby with the same tissue type as their son, Zain, in order to treat his rare blood disorder.

Their attempt failed when Mrs. Hashmi, 38, suffered a miscarriage.

The case was taken to the Law Lords by a pro-life group, Comment on Reproductive Ethics (CORE), which argued that the whole concept of ‘designer babies’ was against British law.

In their ruling, the five-judge panel that heard the case last month ruled that the Human Fertilization and Embryology Authority could authorize the practice of tissue typing to create babies to help siblings.

Set up under the Human Fertilization and Embryology Act 1990, the authority has the power to issue licenses to create or keep an embryo.

It granted a license permitting the treatment in the Hashmi family’s case.

However, it was challenged by Josephine Quintavalle, the founder of CORE, who initially succeeded in getting the High Court to rule that it had no power to grant the license.

The Hashmis, from Leeds in central England, were forced to fight a long legal battle for the treatment, which they say is the only hope for their 6-year-old son.

Zain had been born with beta thalassemia major, a serious and potentially fatal genetic disorder. His body does not produce sufficient red blood cells, and he must take a mix of drugs daily and needs regular blood transfusions to stay alive.

His parents wanted him to undergo stem-cell treatment, using umbilical-cord blood taken from a baby that they would produce using in vitro fertilization treatment and specially selected at the embryo stage so that its tissue matched Zain’s.

Lord Leonard Hoffman, giving the lead judgment, said Mrs. Hashmi twice had conceived naturally in the hope of giving birth to a child whose umbilical blood could provide stem cells for Zain.

On the first attempt, the fetus was found to have beta thalassemia major and she had an abortion. On the second occasion, she gave birth to a child whose tissue turned out not to be compatible.

‘There is a way to save the Hashmi family from having to play dice with conception,’ Lord Hoffman said.

This involved removing a single cell from a newly fertilized embryo and testing it for genetic disorders in a process called preimplantation genetic diagnosis (PGD).

‘Mrs Hashmi, for example, would have been spared having to have her fetus carrying beta thalassemia major aborted if the embryo had been created by [in vitro fertilization] and the disorder diagnosed by PGD,’ the judge said.

Lord Hoffman also noted that the British Parliament never had stated that the testing of embryos to enable the mother to choose to carry a child with the characteristics of her choice was outlawed.

Copyright © 2022 The Washington Times, LLC. Click here for reprint permission.

Please read our comment policy before commenting.

Click to Read More and View Comments

Click to Hide